Delivery Order SPE2DB20D1100-SPE2DB24FD4Q3
Award Date
8/26/24
Potential Completion Date
8/27/24
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty medication. The award has a firm fixed price of $60,133.63 and a completion date of November 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026,...
This is a $33,212.71 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The order has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support...
This is a $9,914.10 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4565828592 DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of...
This is a $6,609.40 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the drug DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $109,594.31 firm fixed-price delivery order is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a completion date of January 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has a ceiling value of $55,282.35 and runs through July 24, 2024. It was awarded on a firm fixed-price basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and will be responsible for delivering the required medical product to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,685.72 firm fixed-price contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 15, 2023 and was awarded on December 14, 2023. This award is associated with Amerisourcebergen's $999,999,999 Indefinite...
This is a $17,138.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has an ultimate completion date of May 8, 2023. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $7,508.63 firm fixed-price contract is for the provision of DUPIXENT 300 MG/2 ML PEN 2ML, with a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product. The delivery order has a ceiling value of $42,990.36 and a completion date of September 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not set aside for any special designation. This contract is part of a larger...